Viewing Study NCT00286169


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2025-12-25 @ 8:35 PM
Study NCT ID: NCT00286169
Status: TERMINATED
Last Update Posted: 2022-04-12
First Post: 2006-02-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)
Sponsor: Sumitomo Pharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module